We are aware of an issue causing the title of some ARTG entries to disappear. We are investigating as a priority and hope to have this resolved as soon as possible.
About this guideline
Overseas effective date: 1 Apr 2014
Replaces: EMEA 410/01 Rev 2 (adopted by the TGA 20 September 2005)
Categories: Biological medicines | Drug product | Transmissible spongiform encephalopathies (TSE) (animal and human)
Access this international scientific guideline
TGA annotations
This EU Guideline should be interpreted in the context of the TGA Supplementary information on Transmissible Spongiform Encephalopathies (TSEs) regulation.
Adoption of this EU Guideline is in line with current pharmacopoeial standards.
For more information see International scientific guidelines adopted in Australia.
Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.